EU CLOSE TO WRAPPING UP PRELIMINARY TALKS WITH U.S. FIRM NOVAVAX FOR THE SUPPLY OF POTENTIAL COVID-19 VACCINE - EU SOURCE
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.795 USD | +1.80% | +19.24% | -1.88% |
Apr. 15 | Sector Update: Health Care Stocks Gain Monday Afternoon | MT |
Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.88% | 657M | |
+26.28% | 48.09B | |
+47.24% | 40.62B | |
-3.99% | 40.43B | |
-6.20% | 28.36B | |
+6.36% | 24.89B | |
-21.47% | 19.01B | |
+27.58% | 12.09B | |
-2.02% | 11.88B | |
-2.75% | 11.8B |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- Eu Close To Wrapping Up Preliminary Talks With U.s. Firm Novavax For The Supply Of Potential Covid-19 Vaccine - Eu Source